Kideny disease
Positive phase III results achieved for dialysis drug in China
April 30, 2021Medical Communications China, Kideny disease
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …
Latest content
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
